Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. (CDTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CDTX · as of Jun 8, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
2
12 Months
Buy/Sell ratio
1.50
Buy/Sell (by trades)
Overall sentiment
Cidara Therapeutics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CDTX insider buying and selling by quarter
CDTX insider selling · CDTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CDTX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CDTX executive sell shares · CDTX board member insider trading · CDTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 7, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Option | 1,286,786 | $129 | Form 4 |
| Jan 7, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Other | 4,652,309 | $1.03B⚡ | Form 4 |
| Jan 7, 2026 | Bassler Bonnie L Director | Other | 15 | $3K | Form 4 |
| Jan 7, 2026 | Mineo Chrysa Director | Other | 3,320 | $735K | Form 4 |
| Jan 7, 2026 | BURGESS DANIEL D Director | Other | 150 | $33K | Form 4 |
| Jan 7, 2026 | Stein Jeffrey President & CEO · Director | Other | 67,498 | $14.95M⚡ | Form 4 |
| Jan 7, 2026 | KARBE FRANK CFO | Other | 7,526 | $1.67M⚡ | Form 4 |
| Jan 7, 2026 | KARBE FRANK CFO | Other | 43,125 | $9.55M⚡ | Form 4 |
| Jan 7, 2026 | Ward Shane COO & CLO | Other | 25,083 | $5.56M⚡ | Form 4 |
| Jan 7, 2026 | Davarpanah Nicole Negar Chief Medical Officer | Other | 12,553 | $2.78M⚡ | Form 4 |
| Jan 7, 2026 | Davarpanah Nicole Negar Chief Medical Officer | Other | 8,333 | $1.85M⚡ | Form 4 |
| Nov 10, 2020 | Stein Jeffrey President & CEO · Director | Purchase | 2,500 | $100K | Form 4 |
| Dec 31, 2021 | Stein Jeffrey President & CEO · Director | Gift | 1,873 | — | Form 4 |
| Sep 12, 2017 | Stein Jeffrey President & CEO · Director | Purchase | 367 | $50K | Form 4 |
| Jun 5, 2017 | Stein Jeffrey President & CEO · Director | Purchase | 750 | $89K | Form 4 |
| Mar 31, 2017 | Stein Jeffrey President & CEO · Director | Purchase | 645 | $100K | Form 4 |
| May 23, 2016 | Stein Jeffrey President & CEO · Director | Other | 270 | — | Form 4 |
| Mar 31, 2017 | Stein Jeffrey President & CEO · Director | Other | 645 | $100K | Form 4 |
| Jun 5, 2017 | Stein Jeffrey President & CEO · Director | Other | 750 | $89K | Form 4 |
| Sep 12, 2017 | Stein Jeffrey President & CEO · Director | Other | 367 | $50K | Form 4 |
RA CAPITAL MANAGEMENT, L.P.
Director
Date
Jan 7
Shares
1,286,786
Price
$0.00
Value
$129
RA CAPITAL MANAGEMENT, L.P.
Director
Date
Jan 7
Shares
4,652,309
Price
$221.50
Value
$1.03B ⚡
Stein Jeffrey
President & CEO · Director
Date
Jan 7
Shares
67,498
Price
$221.50
Value
$14.95M ⚡
Davarpanah Nicole Negar
Chief Medical Officer
Date
Jan 7
Shares
12,553
Price
$221.50
Value
$2.78M ⚡
Davarpanah Nicole Negar
Chief Medical Officer
Date
Jan 7
Shares
8,333
Price
$221.50
Value
$1.85M ⚡
Stein Jeffrey
President & CEO · Director
Date
Nov 10
Shares
2,500
Price
$40.01
Value
$100K
Stein Jeffrey
President & CEO · Director
Date
Sep 12
Shares
367
Price
$135.80
Value
$50K
Stein Jeffrey
President & CEO · Director
Date
Jun 5
Shares
750
Price
$118.95
Value
$89K
Stein Jeffrey
President & CEO · Director
Date
Mar 31
Shares
645
Price
$155.00
Value
$100K
Stein Jeffrey
President & CEO · Director
Date
Mar 31
Shares
645
Price
$155.00
Value
$100K
Stein Jeffrey
President & CEO · Director
Date
Jun 5
Shares
750
Price
$118.95
Value
$89K
Stein Jeffrey
President & CEO · Director
Date
Sep 12
Shares
367
Price
$135.80
Value
$50K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CDTX insider trading
CDTX insider trades
Cidara Therapeutics, Inc. (CDTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including RA CAPITAL MANAGEMENT, L.P. (Director), KARBE FRANK (CFO), Davarpanah Nicole Negar (Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. CDTX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Cidara Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CDTX insider trading · 5 questionsThe insiders of Cidara Therapeutics, Inc. (CDTX) include executives and directors such as RA CAPITAL MANAGEMENT, L.P. (Director), KARBE FRANK (CFO), Davarpanah Nicole Negar (Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026